BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29296225)

  • 1. Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer.
    Xie Z; Liang H; Wang J; Xu X; Zhu Y; Guo A; Shen X; Cao F; Chang W
    Oncotarget; 2017 Dec; 8(64):108079-108092. PubMed ID: 29296225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBR5 oncogene as an indicator of poor prognosis in gastric cancer.
    Ding F; Zhu X; Song X; Yuan P; Ren L; Chai C; Zhou W; Li X
    Exp Ther Med; 2020 Nov; 20(5):7. PubMed ID: 32934672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer.
    Shearer RF; Iconomou M; Watts CK; Saunders DN
    Mol Cancer Res; 2015 Dec; 13(12):1523-32. PubMed ID: 26464214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
    Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role and molecular mechanism of metabolic reprogramming of colorectal cancer by UBR5 through PYK2 regulation of OXPHOS expression study.
    Qin R; Huang Y; Yao Y; Wang L; Zhang Z; Huang W; Su Y; Zhang Y; Guan A; Wang H
    J Biochem Mol Toxicol; 2023 Aug; 37(8):e23376. PubMed ID: 37098808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
    Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
    Front Oncol; 2021; 11():634167. PubMed ID: 33777788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of UBR5 promotes tumor growth in gallbladder cancer via PTEN/PI3K/Akt signal pathway.
    Zhang Z; Zheng X; Li J; Duan J; Cui L; Yang L; Zhang L; Zhang Q; Wang X
    J Cell Biochem; 2019 Jul; 120(7):11517-11524. PubMed ID: 30775814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research advancements on the involvement of E3 ubiquitin ligase UBR5 in gastrointestinal cancers.
    Qin R; Fan X; Ding R; Qiu Y; Chen X; Liu Y; Lin M; Wang H
    Heliyon; 2024 May; 10(9):e30284. PubMed ID: 38707379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD.
    Bethard JR; Zheng H; Roberts L; Eblen ST
    J Proteomics; 2011 Dec; 75(2):603-9. PubMed ID: 21924388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients.
    Huo Q; Hu J; Hou B; Zhao M; Han X; Du Y; Li Y
    Pathol Oncol Res; 2022; 28():1610396. PubMed ID: 36388433
    [No Abstract]   [Full Text] [Related]  

  • 13. SUB1 promotes colorectal cancer metastasis by activating NF-κB signaling via UBR5-mediated ubiquitination of UBXN1.
    Wang H; Chen W; Wang Y; Gao Y; Zhang Z; Mi S; Wang L; Xue M
    Sci China Life Sci; 2024 Jan; ():. PubMed ID: 38240906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
    Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum DAND5 is associated with metastasis and predicts poor prognosis in colorectal cancer.
    Miao X; Zhang Y; Sun J; Cui S; Meng Q; Zhu K; Hu X; Wang T
    United European Gastroenterol J; 2017 Aug; 5(5):725-734. PubMed ID: 28815037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
    Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
    Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ubiquitin ligase Smurf2: a prognostic factor in microsatellite stable colorectal cancer.
    Klupp F; Giese C; Halama N; Franz C; Lasitschka F; Warth A; Schmidt T; Kloor M; Ulrich A; Schneider M
    Cancer Manag Res; 2019; 11():1795-1803. PubMed ID: 30863185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.